Selected research
Industry Research
NAD+ Booster Capsule Industry Research Report 2026
Market perspective
The global NAD+ Booster Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NAD+ Booster Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NAD+ Booster Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NAD+ Booster Capsule include EffePharm, Kingdomway, GeneHarbor, Bontac, NOMON Co., Ltd. (Teijin), Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Maac10 Formulas, Herbalmax and Genex Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NAD+ Booster Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NAD+ Booster Capsule Market by Company
EffePharm
Kingdomway
GeneHarbor
Bontac
NOMON Co., Ltd. (Teijin)
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Maac10 Formulas
Herbalmax
Genex Formulas
EZZ
Elysium Health
Chromadex
CELFULL
NAD+ Booster Capsule Segment by Type
Content ＜98%
Content ≥98%
NAD+ Booster Capsule Segment by Application
Health Care Products
Beauty Products
Others
NAD+ Booster Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Booster Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ Booster Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Booster Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NAD+ Booster Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NAD+ Booster Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NAD+ Booster Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Content ＜98%
- Content ≥98%
Applications
- Health Care Products
- Beauty Products
- Others
Companies covered
- EffePharm
- Kingdomway
- GeneHarbor
- Bontac
- NOMON Co., Ltd. (Teijin)
- Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- Maac10 Formulas
- Herbalmax
- Genex Formulas
- EZZ
- Elysium Health
- Chromadex
- CELFULL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global NAD+ Booster Capsule Market Size (2021-2032)
- 2.2.2 Global NAD+ Booster Capsule Sales (2021-2032)
- 2.2.3 Global NAD+ Booster Capsule Market Average Price (2021-2032)
- 2.3 NAD+ Booster Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Content ＜98%
- 2.3.3 Content ≥98%
- 2.4 NAD+ Booster Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Care Products
- 2.4.3 Beauty Products
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NAD+ Booster Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global NAD+ Booster Capsule Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global NAD+ Booster Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global NAD+ Booster Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global NAD+ Booster Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of NAD+ Booster Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of NAD+ Booster Capsule, Product Type & Application
- 3.8 Global Manufacturers of NAD+ Booster Capsule, Established Date
- 3.9 Global NAD+ Booster Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 EffePharm
- 4.1.1 EffePharm Company Information
- 4.1.2 EffePharm Business Overview
- 4.1.3 EffePharm NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 EffePharm NAD+ Booster Capsule Product Portfolio
- 4.1.5 EffePharm Recent Developments
- 4.2 Kingdomway
- 4.2.1 Kingdomway Company Information
- 4.2.2 Kingdomway Business Overview
- 4.2.3 Kingdomway NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kingdomway NAD+ Booster Capsule Product Portfolio
- 4.2.5 Kingdomway Recent Developments
- 4.3 GeneHarbor
- 4.3.1 GeneHarbor Company Information
- 4.3.2 GeneHarbor Business Overview
- 4.3.3 GeneHarbor NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GeneHarbor NAD+ Booster Capsule Product Portfolio
- 4.3.5 GeneHarbor Recent Developments
- 4.4 Bontac
- 4.4.1 Bontac Company Information
- 4.4.2 Bontac Business Overview
- 4.4.3 Bontac NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bontac NAD+ Booster Capsule Product Portfolio
- 4.4.5 Bontac Recent Developments
- 4.5 NOMON Co., Ltd. (Teijin)
- 4.5.1 NOMON Co., Ltd. (Teijin) Company Information
- 4.5.2 NOMON Co., Ltd. (Teijin) Business Overview
- 4.5.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio
- 4.5.5 NOMON Co., Ltd. (Teijin) Recent Developments
- 4.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- 4.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
- 4.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
- 4.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio
- 4.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
- 4.7 Maac10 Formulas
- 4.7.1 Maac10 Formulas Company Information
- 4.7.2 Maac10 Formulas Business Overview
- 4.7.3 Maac10 Formulas NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Maac10 Formulas NAD+ Booster Capsule Product Portfolio
- 4.7.5 Maac10 Formulas Recent Developments
- 4.8 Herbalmax
- 4.8.1 Herbalmax Company Information
- 4.8.2 Herbalmax Business Overview
- 4.8.3 Herbalmax NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Herbalmax NAD+ Booster Capsule Product Portfolio
- 4.8.5 Herbalmax Recent Developments
- 4.9 Genex Formulas
- 4.9.1 Genex Formulas Company Information
- 4.9.2 Genex Formulas Business Overview
- 4.9.3 Genex Formulas NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Genex Formulas NAD+ Booster Capsule Product Portfolio
- 4.9.5 Genex Formulas Recent Developments
- 4.10 EZZ
- 4.10.1 EZZ Company Information
- 4.10.2 EZZ Business Overview
- 4.10.3 EZZ NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 EZZ NAD+ Booster Capsule Product Portfolio
- 4.10.5 EZZ Recent Developments
- 4.11 Elysium Health
- 4.11.1 Elysium Health Company Information
- 4.11.2 Elysium Health Business Overview
- 4.11.3 Elysium Health NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Elysium Health NAD+ Booster Capsule Product Portfolio
- 4.11.5 Elysium Health Recent Developments
- 4.12 Chromadex
- 4.12.1 Chromadex Company Information
- 4.12.2 Chromadex Business Overview
- 4.12.3 Chromadex NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chromadex NAD+ Booster Capsule Product Portfolio
- 4.12.5 Chromadex Recent Developments
- 4.13 CELFULL
- 4.13.1 CELFULL Company Information
- 4.13.2 CELFULL Business Overview
- 4.13.3 CELFULL NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CELFULL NAD+ Booster Capsule Product Portfolio
- 4.13.5 CELFULL Recent Developments
5 Global NAD+ Booster Capsule Market Scenario by Region
- 5.1 Global NAD+ Booster Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global NAD+ Booster Capsule Sales by Region: 2021-2032
- 5.2.1 Global NAD+ Booster Capsule Sales by Region: 2021-2026
- 5.2.2 Global NAD+ Booster Capsule Sales by Region: 2027-2032
- 5.3 Global NAD+ Booster Capsule Revenue by Region: 2021-2032
- 5.3.1 Global NAD+ Booster Capsule Revenue by Region: 2021-2026
- 5.3.2 Global NAD+ Booster Capsule Revenue by Region: 2027-2032
- 5.4 North America NAD+ Booster Capsule Market Facts & Figures by Country
- 5.4.1 North America NAD+ Booster Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America NAD+ Booster Capsule Sales by Country (2021-2032)
- 5.4.3 North America NAD+ Booster Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe NAD+ Booster Capsule Market Facts & Figures by Country
- 5.5.1 Europe NAD+ Booster Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe NAD+ Booster Capsule Sales by Country (2021-2032)
- 5.5.3 Europe NAD+ Booster Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific NAD+ Booster Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific NAD+ Booster Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific NAD+ Booster Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific NAD+ Booster Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America NAD+ Booster Capsule Market Facts & Figures by Country
- 5.7.1 South America NAD+ Booster Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America NAD+ Booster Capsule Sales by Country (2021-2032)
- 5.7.3 South America NAD+ Booster Capsule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa NAD+ Booster Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa NAD+ Booster Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa NAD+ Booster Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa NAD+ Booster Capsule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global NAD+ Booster Capsule Sales by Type (2021-2032)
- 6.1.1 Global NAD+ Booster Capsule Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global NAD+ Booster Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global NAD+ Booster Capsule Revenue by Type (2021-2032)
- 6.2.1 Global NAD+ Booster Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global NAD+ Booster Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global NAD+ Booster Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global NAD+ Booster Capsule Sales by Application (2021-2032)
- 7.1.1 Global NAD+ Booster Capsule Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global NAD+ Booster Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global NAD+ Booster Capsule Revenue by Application (2021-2032)
- 7.2.1 Global NAD+ Booster Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global NAD+ Booster Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global NAD+ Booster Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 NAD+ Booster Capsule Value Chain Analysis
- 8.1.1 NAD+ Booster Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 NAD+ Booster Capsule Production Mode & Process
- 8.2 NAD+ Booster Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 NAD+ Booster Capsule Distributors
- 8.2.3 NAD+ Booster Capsule Customers
9 Global NAD+ Booster Capsule Analyzing Market Dynamics
- 9.1 NAD+ Booster Capsule Industry Trends
- 9.2 NAD+ Booster Capsule Industry Drivers
- 9.3 NAD+ Booster Capsule Industry Opportunities and Challenges
- 9.4 NAD+ Booster Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst